(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 31.12%6.6B | 40.27%4.73B | 17.92%2.78B | 41.75%1.43B | 38.73%5.03B | 19.40%3.37B | 30.02%2.36B | 18.04%1.01B | 7.24%3.63B | 52.96%2.83B |
Operating income | 31.12%6.6B | 40.27%4.73B | 17.92%2.78B | 41.75%1.43B | 38.73%5.03B | 19.40%3.37B | 30.02%2.36B | 18.04%1.01B | 7.24%3.63B | 52.96%2.83B |
Operating expenses | -31.51%-5.83B | -39.12%-4.19B | -18.15%-2.48B | -44.14%-1.29B | -59.94%-4.43B | -47.75%-3.01B | -68.43%-2.1B | -76.09%-892.54M | -13.88%-2.77B | -47.79%-2.04B |
Gross profit | 28.16%764M | 49.83%544.28M | 16.07%296M | 23.06%139.96M | -30.16%596.12M | -53.90%363.28M | -54.85%255.01M | -67.09%113.73M | -9.84%853.6M | 68.14%788.06M |
Selling expenses | -13.45%-19.77M | -47.93%-19.78M | -71.96%-12.14M | -118.06%-7.66M | 9.71%-17.43M | 8.56%-13.37M | 14.11%-7.06M | 33.87%-3.51M | 18.24%-19.3M | 76.41%-14.63M |
Administrative expenses | -16.52%-147.12M | -28.80%-108.96M | -29.31%-71.42M | -24.93%-35.43M | 27.81%-126.26M | 22.11%-84.6M | 24.54%-55.23M | 31.68%-28.36M | -27.69%-174.9M | -35.10%-108.61M |
Research and development expenses | -44.73%-251.52M | -40.10%-175.1M | -30.29%-107.23M | -48.72%-58.2M | -12.61%-173.79M | 0.29%-124.98M | 8.79%-82.3M | 28.73%-39.14M | -27.81%-154.33M | -95.02%-125.34M |
Profit from asset sales | 2,805.00%45.11M | 35,106.83%11.31M | 92.70%-5.14K | 49.54%-35.52K | 546.21%1.55M | 80.76%-32.31K | 42.38%-70.38K | -283.89%-70.38K | -34.19%-347.98K | 16.55%-167.94K |
Impairment and provision | 134.44%6.68M | 140.15%1.31M | 128.83%2.4M | 185.22%4.15M | -35.50%-19.41M | -790.84%-3.25M | -1,003.12%-8.33M | -23.86%1.45M | -1,310.61%-14.32M | 107.75%470.64K |
-Other impairment is provision | 134.44%6.68M | 140.15%1.31M | 128.83%2.4M | 185.22%4.15M | -35.50%-19.41M | -790.84%-3.25M | -1,003.12%-8.33M | -23.86%1.45M | -1,310.61%-14.32M | 107.75%470.64K |
Special items of operating profit | -30.18%222.08M | -54.65%110.61M | -50.09%115.74M | -89.89%11.32M | 1,153.89%318.06M | 1,298.24%243.91M | 1,927.25%231.93M | 5,572.80%111.97M | -44.64%25.37M | 139.71%17.44M |
Operating profit | 6.36%575M | -6.09%334.31M | -36.21%203.14M | -69.62%45.48M | 14.30%540.61M | -32.26%355.98M | -17.15%318.47M | -36.39%149.74M | -29.58%472.97M | 117.71%525.49M |
Financing cost | -0.81%-74.13M | -16.13%-60.96M | 1.32%-36.68M | 1.29%-17.78M | 41.20%-73.53M | 45.74%-52.49M | 46.99%-37.17M | 45.29%-18.01M | 6.44%-125.07M | -6.33%-96.74M |
Special items of earning before tax | -84.25%503.21K | -71.73%471.46K | -34.50%460.83K | -98.14%2.96K | -0.04%3.2M | -61.25%1.67M | 242.26%703.58K | 186.03%159.67K | -28.71%3.2M | 196.84%4.3M |
Earning before tax | 6.61%501.37M | -10.27%273.82M | -40.81%166.92M | -78.99%27.7M | 33.94%470.27M | -29.53%305.16M | -10.13%282M | -34.80%131.88M | -35.27%351.1M | 185.20%433.06M |
Tax | -229.43%-36.56M | -143.87%-28.46M | -44.94%-12.6M | 40.46%-5.91M | 43.88%-11.1M | 75.46%-11.67M | 80.09%-8.69M | 68.40%-9.93M | 71.82%-19.78M | -76.06%-47.54M |
After-tax profit from continuing operations | 41.93%464.82M | 51.63%245.37M | -42.44%154.32M | -53.99%21.79M | 18.43%327.51M | -58.02%161.82M | -0.76%268.1M | -72.28%47.35M | -41.44%276.55M | 208.81%385.52M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | 140.36%131.66M | --131.66M | --5.21M | --74.6M | --54.78M | ---- |
Adjustment items of earning after tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --140.92M | ---- |
Earning after tax | 1.23%464.82M | -16.40%245.37M | -43.54%154.32M | -82.13%21.79M | -2.77%459.17M | -23.87%293.49M | 1.17%273.31M | -28.62%121.95M | 0.00%472.25M | 208.81%385.52M |
Minority profit | 39.83%70.1M | 46.16%47.51M | 0.62%25.58M | -5.77%9.34M | -33.66%50.13M | -50.69%32.51M | -38.64%25.42M | -53.45%9.92M | -23.96%75.57M | 91.91%65.92M |
Special items of profit attributable to shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --140.92M | ---- |
Profit attributable to shareholders | -3.50%394.72M | -24.19%197.86M | -48.06%128.74M | -88.89%12.45M | 59.93%409.04M | -18.34%260.98M | 8.39%247.89M | -25.08%112.04M | -31.41%255.76M | 253.18%319.6M |
Basic earnings per share | -3.17%0.61 | -22.50%0.31 | -47.37%0.2 | -88.24%0.02 | 43.18%0.63 | -29.82%0.4 | -9.52%0.38 | -37.04%0.17 | -35.29%0.44 | 247.99%0.57 |
Diluted earnings per share | -3.17%0.61 | -22.50%0.31 | -47.37%0.2 | -88.24%0.02 | 43.18%0.63 | -29.82%0.4 | -9.52%0.38 | -37.04%0.17 | -35.29%0.44 | 247.99%0.57 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Grant Tung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Tung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data